Copley To Expand Into Generic Injectables Through Joint Ventures
Executive Summary
Copley is planning an expansion into injectable generic pharmaceuticals, potentially through joint ventures or royalty arrangements, CEO Daniel Korpolinski said Oct. 26 during the CIBC Oppenheimer Health Care Conference in New York City.